GARDASIL 9

Injektionssuspension in einer Fertigspritze, 30mcg/0.5ml + 40mcg/0.5ml + 60mcg/0.5ml + 40mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml

RezeptpflichtigAktive Zulassung

Wirkstoff (INN)

Humaner-Papillomvirus-9-valenter-Impfstoff (Typen 6, 11, 16, 18, 31, 33, 45, 52, 58), rekombinant, adsorbiert

Darreichungsform

DarreichungsformInjektionssuspension in einer Fertigspritze

Stärke30mcg/0.5ml + 40mcg/0.5ml + 60mcg/0.5ml + 40mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml + 20mcg/0.5ml

VerpackungUkupno 1 napunjeni injekcioni špric sa 0.5ml suspenzije za injekciju (sa 2 igle) u kartonskoj kutiji

HerstellerMerck Sharp & Dohme B.V., Niederlande

Therapeutische GruppeAntiinfektiva zur systemischen Anwendung (J07BM03)

ZulassungsinhaberDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA

Zulassungsdatum10. November 2025

Quelle: CInMED-Register